Evidence map›Paper›PMID 24798210›Full record

Trial reportPloS one2014

Medication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction Profile.

Marie E Gabe, Fiona Murphy, Gwyneth A Davies, Ian T Russell, Susan Jordan

2 registry-linked trialsOpen access · goldAbstract readPragmatic Clinical Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03110471 completednot on this mapstarted 2017, after this paper: background citation

Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation of the Impact and Sustainability of the West Wales Adverse Drug Reaction (WWADR) Profile and Pharmacist Involvement

TypeobservationalSponsorSwansea UniversityRan2017 to 2018Enrolled60ConditionsDementiaArmsWest Wales Adverse Drug Reaction (WWADR) Profile, usual care
NCT04663360 nacompletednot on this mapstarted 2020, after this paper: background citation

Medication Monitoring in General Practice: Clinical Impact of Implementing a Nurse-led Adverse Drug Reaction (ADRe) Profile in Older Adults With 5 or More Prescribed Medicines

TypeinterventionalSponsorSwansea UniversityRan2020 to 2020Enrolled19ConditionsPolypharmacyArmsAdverse Drug Reaction (ADRe) Profile
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. A qualitative exploration of patient safety in a hospital setting in Spain: Policy and practice recommendations on patients' and companions' participation.Health expectations : an international journal of public participation in health care and health policy · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marie E GabeCollege of Human and Health Sciences, Swansea University, Swansea, United Kingdom.
Fiona MurphyCollege of Human and Health Sciences, Swansea University, Swansea, United Kingdom.
Gwyneth A DaviesABM University Health Board, Wales, United Kingdom; College of Medicine, Swansea University, Swansea, United Kingdom.
Ian T RussellWest Wales Organisation for Rigorous Trials in Health, and College of Medicine, Swansea University, Swansea, United Kingdom.
Susan JordanCollege of Human and Health Sciences, Swansea University, Swansea, United Kingdom.
Swansea University · GBSwansea Bay University Health Board · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the clinical effect of medication monitoring using the West Wales Adverse Drug Reaction (ADR) Profile for Respiratory Medicine.

designSingle-site parallel-arm pragmatic trial using stratified randomisation.

settingNurse-led respiratory outpatient clinic in general hospital in South Wales.

participants54 patients with chronic respiratory disease receiving bronchodilators, corticosteroids or leukotriene receptor antagonists.

interventionFollowing initial observation of usual nursing care, we allocated participants at random to receive at follow up: either the West Wales ADR Profile for Respiratory Medicine in addition to usual care ('intervention arm' with 26 participants); or usual care alone ('control arm' with 28 participants).

main outcome measuresProblems reported and actions taken.

resultsWe followed up all randomised participants, and analysed data in accordance with treatment allocated. The increase in numbers of problems per participant identified at follow up was significantly higher in the intervention arm, where the median increase was 20.5 [inter-quartile range (IQR) 13-26], while that in the control arm was -1 [-3 to +2] [Mann-Whitney U test: z = 6.28, p<0.001]. The increase in numbers of actions per participant taken at follow up was also significantly higher in the intervention arm, where the median increase was 2.5 [1]-[4] while that in the control arm was 0 [-1.75 to +1] [Mann-Whitney U test: z = 4.40, p<0.001].

conclusionWhen added to usual nursing care, the West Wales ADR Profile identified more problems and prompted more nursing actions. Our ADR Profile warrants further investigation as a strategy to optimise medication management.

trial registrationControlled-trials.com ISRCTN10386209.

Indexed as

Adverse Drug Reaction Reporting SystemsDrug MonitoringDrug-Related Side Effects and Adverse ReactionsAdrenal Cortex HormonesAgedAmbulatory Care FacilitiesBronchodilator AgentsFemaleFollow-Up StudiesHumansLeukotriene AntagonistsMaleMiddle AgedNursesNursingOutpatientsAdrenal Cortex HormonesBronchodilator AgentsLeukotriene Antagonists

Identifiers

PMID24798210
PMCPMC4010491
OpenAlexW2027872468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.